Reactivation of silent fetal or embryonic genes could be used for the
treatment of genetic diseases caused by mutations of genes normally ex
pressed during the adult stage of development. A paradigm of this appr
oach is the activation of fetal hemoglobin synthesis in adult individu
als and its use in the treatment of beta chain hemoglobinopathies. The
current understanding of the molecular control of the beta globin loc
us is reviewed, as are the cellular and molecular basis of induction o
f fetal hemoglobin in the adult and the approaches used for stimulatio
n of fetal hemoglobin synthesis in patients with beta chain hemoglobin
opathies.